Search Results
Baxter Publishes Annual Corporate Responsibility Report, Reinforcing Longstanding Commitment to Making a Meaningful Difference
Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2022 Corporate Responsibility Report.
Toddler by Day, Kidney Care Superhero by Night
During the daytime, Nicklaus lives an active life of a two-year-old, playing with his older brother and keeping his parents on their toes. You would never know this energetic toddler has battled kidney disease since birth, requiring nightly dialysis treatments at home, while he waits for a kidney transplant.
Baxter to Host Second-Quarter 2023 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2023 financial results on Thursday, July 27, 2023 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/XvgzXupv to pre-register for the call and receive the call information.
Baxter to Present at Jefferies Healthcare Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023. José (Joe) Almeida, Baxter's chairman, president and chief executive officer, is scheduled to present at 10:00 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Wednesday, September 6, 2023.
Supply Chain Innovation Delivers More Nimble, Efficient Solutions
The COVID-19 pandemic exposed the fragility of the global supply chain. Want to renovate your house? Expect a 6-month delay in building materials. Buying a smartphone? With an astounding 2,000 components in many of the latest models, just one missing element creates a bottleneck in manufacturing and represents billions of dollars in lost revenue. Similar supply chain threats exist in the medtech industry.
Driving a Safe Culture
Christopher Nelson, a service specialist based in Earth City, Mo., was recently inducted into the National Private Truck Council Driver Hall of Fame. He has demonstrated a remarkable commitment to safety and unwavering dedication to kidney patients over the course of his 35-year career.
Baxter Announces CFO Transition
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the departure of executive vice president and chief financial officer (CFO) Jay Saccaro. Mr. Saccaro will leave Baxter at the end of May after 21 cumulative years with the company, including the past eight as CFO, to join a company in the healthcare industry.
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business to Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.
Baxter Names Chris Toth CEO of Proposed Kidney Care Spinoff
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has selected Chris Toth to be chief executive officer (CEO) of the company’s planned spinoff of its Renal Care and Acute Therapies businesses. Until the spinoff, which remains subject to satisfaction of customary conditions and is currently expected to occur by July 2024 or earlier, Mr.
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on July 3, 2023, to shareholders of record as of June 2, 2023. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter